Epicentre
Quick facts
Marketed products
- Artesunate-amodiaquine fixed-dose combination · Infectious Disease
Artesunate and amodiaquine work synergistically to kill malaria parasites by generating reactive oxygen species and disrupting parasite metabolism. - Delayed second dose of oral cholera vaccine, Euvichol-Plus
- PCV10 fractional dose
- PCV10 full dose · Immunology
PCV10 is a pneumococcal conjugate vaccine that stimulates the immune system to produce antibodies against 10 serotypes of Streptococcus pneumoniae. - Stamaril, Sanofi Pasteur · Immunology / Infectious Disease
Stamaril is a live attenuated yellow fever vaccine that stimulates the immune system to produce antibodies and cellular immunity against yellow fever virus. - Yellow fever vaccine, Bio-Manguinhos
- Yellow fever vaccine, Chumakov Institute
Phase 3 pipeline
- Rotavirus vaccine (BRV-PV) · Immunology / Infectious Disease
BRV-PV is a live attenuated rotavirus vaccine that stimulates immune responses to prevent rotavirus gastroenteritis.
Phase 1 pipeline
- Artemether-lumefantrine fixed combination · Infectious Disease
Artemether is a fast-acting antimalarial that acts by inhibiting the parasite's mitochondrial electron transport chain, while lumefantrine is a slow-acting antimalarial that acts by inhibiting the parasite's heme detoxification pathway. - ASAQ Winthrop® Sanofi Aventis · Infectious Disease
Artemisinin and Amodiaquine combination - Coartem®, Novartis
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: